Viewing Study NCT01654692


Ignite Creation Date: 2025-12-24 @ 3:44 PM
Ignite Modification Date: 2025-12-27 @ 8:45 PM
Study NCT ID: NCT01654692
Status: COMPLETED
Last Update Posted: 2015-05-13
First Post: 2012-07-18
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Combination of Ipilimumab and Fotemustine for Treat Unresectable Locally Advanced or Metastatic Melanoma
Sponsor: Italian Network for Tumor Biotherapy
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module